Results

Total Results: 1,277 records

Showing results for "death".

21. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
    February 01, 2009 - Risk of death in elderly users of conventional vs. atypical antipsychotic medications. … Antipsychotics and the risk of sudden cardiac death. … Thioridazine and sudden unexplained death in psychiatric inpatients. … Antipsychotics and the risk of sudden cardiac death. … Antipsychotic drugs: prolonged QTc Interval, Torsade de Pointes, and sudden death.

22. CER 244 Evidence Summary: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
    May 01, 2021 - update) Low: No evidence of increased risk of asthma, autoimmune disease, cardiovascular events, death … cardiovascular events, stroke Low: No evidence of increased risk of asthma, autoimmune disease, death … ®], MenACWY-CRM [Menveo®], MenACWY-TT [MenQuadfi®]) Moderate: No evidence of increased risk of death … evidence of increased risk or insufficient evidence) Moderate: No evidence of increased risk of death … Influenza, live attenuated (LAIV; FluMist Quadrivalent) Low: No evidence of increased risk of death

23. Potential Causes of Higher Mortality Among Elderly Users of Conventional Versus Atypical Antipsychotics | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/antipsychotic-medicine-mortality-elderly/research
    November 01, 2017 - growing that conventiona lantipsychotic medication (APM )use maybe associated with greater risks of death … potential mechanisms through the conventionals might act, we sought to compare the specific causes of death … higher adjusted hazard of all CV (hazard ratio [HR] 1.23; 95% CI 1.10-1.36), and out-of-hospital CV death … Initiators of conventional APMs also had a higher risk for death due to respiratory diseases, nervous … The risk of death due to respiratory causes was also significantly higher in conventional APM use.

24. Peripheral Artery Disease (PAD) - defined as peripheral artery disease of the lower extremities 1) Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death) in patients with PAD? Is there a… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-diffe
    November 01, 2017 - extremities 1) Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death … extremities 1) Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death … extremities Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death … extremities 1) Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death … peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-diffe

25. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
    January 01, 2010 - Outcomes including death, myocardial infarction (MI), revascularization, major bleeding, stroke, death … or MI, death or MI or revascularization, and death or MI or stroke, were compared using estimated cumulative … The composite events used in this study were: MI or death, MI or death or revascularization, and MI … or death or stroke. … The unadjusted 30-month rates of death or MI (17% vs. 23%), death or MI or revascularization (32% vs

26. Real World Effectiveness of Carotid Artery Stenting (CAS) in Medicare Patients | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/coronary-stents-effectiveness/abstract
    December 01, 2019 - Background: Stroke is the third leading cause of death … Research Objectives: Aim 1: Demonstrate differences in the overall incidence of death and stroke between … Exposures: CAS, CEA, medical treatment Outcome: Study outcomes include all-death as well as hospitalization

27. Microsoft Word - ehcrr#2toCSI.doc (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
    August 01, 2007 - Research Reports Comparative Safety of Conventional and Atypical Antipsychotic Medications: Risk of Death … We also identified the presence of conditions that are independent predictors of death and were related … Adjusted mortality ratios (MR) comparing the risk of death for initiators of conventional vs. atypical … Risk of death in elderly users of conventional vs. atypical antipsychotic medications. … Sensitivity analysis of the observed association between conventional APM use and death.

28. Interventions to Improve Care of Bereaved Persons (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bereaved-persons-protocol.pdf
    June 01, 2023 - complicated grief or grief with a high level of distress that extends 6 to 12 months following the death … (e.g., expected vs unexpected), preparation for the death, awareness of prognosis, acceptance of death … (e.g., traumatic death, anticipated death, overdose, suicide), and place of death such as the ICU, … (e.g., illness), nature of the death (e.g., sudden death), setting of death (e.g., hospital), relationship … Death Stud. 2015;39(6):347-52. doi: 10.1080/07481187.2014.951498. PMID: 25906168. 18.

29. Interventions to Improve Care of Bereaved Persons | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/bereaved-persons/protocol
    December 01, 2023 - (e.g., expected vs unexpected), preparation for the death, awareness of prognosis, acceptance of death … (e.g., traumatic death, anticipated death, overdose, suicide), and place of death such as the ICU, relationship … (e.g., illness), nature of the death (e.g., sudden death), setting of death (e.g., hospital), relationship … OMEGA - Journal of Death and Dying. 1990;20(4):307-22. doi: 10.2190/a4u5-t46h-b0hj-dbrq. … Death Stud. 2015;39(6):347-52. doi: 10.1080/07481187.2014.951498. PMID: 25906168.

30. Treatment Strategies for Women With Coronary Artery Disease | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/cad-women-treatment/research
    December 01, 2019 - Structured Abstract Objectives Although coronary artery disease (CAD) is the leading cause of death … For women with STEMI, five studies showed a reduction in composite outcomes (primarily death/MI/stroke … benefit of early invasive over initial conservative management for the composite outcome of primarily death … revascularization (PCI or CABG) or medical therapy, three studies showed a reduction in the composite outcome of death … At 1 year and beyond, although suggestive of a benefit of CABG in for the composite outcomes of death

31. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - Results: H-ISDN prescription was not associated with risk of death in five of nine subgroups predefined … , or > 12 months) following heart failure diagnosis), but was associated with an increased risk of death … Death occurred more frequently in the H-ISDN group (46.7%) than in the no H-ISDN group (35.5%). … Hypothesis Testing H0(1): There is no association between exposure to H-ISDN and either time to death … H0(3): There is no association between exposure to H-ISDN and either risk-adjusted time to death or

32. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/cad-women-treatment-future/research
    December 01, 2019 - Excerpt Cardiovascular disease remains the leading cause of death among women in the United States. … cardiovascular disease each year, exceeding the number of deaths in men and the next seven causes of death … This translates into approximately one death every minute.

33. Effectiveness of Isosorbide Dinitrate and Hydralazine in Racial/Ethnic Subgroups With Heart Failure | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/congestive-heart-failure-medicines/research
    January 01, 2020 - Results: H-ISDN prescription was not associated with risk of death in five of nine subgroups predefined … 12, or > 12 months) following heart failure diagnosis), but was associated with an increased risk of death … Index. 12 The dependent variables for our analyses were time to death from any cause and time to the … Death occurred more frequently in the H-ISDN group (46.7%) than in the no H-ISDN group (35.5%). … Hypothesis Testing H0(1): There is no association between exposure to H-ISDN and either time to death

34. Omega-3 Fatty Acids and Cardiovascular Disease: A Review of the Research for Adults (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_consumer.pdf
    July 01, 2017 - affect longer term cardiovascular problems such as the risk of heart attack, heart failure, stroke, death … from heart disease, and death from any cause. … dietary supplements The risk of longer term CV problems (such as heart attack and heart failure) and death … Appears to lower the risk of longer term CV problems (such as heart attack and heart failure) and death … – Do not lower the risk of longer term CV problems (such as heart attack and heart failure) and death

35. Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/opioids-older-adults/report
    January 01, 2022 - hospitalization, nonopioid-specific hospitalization, emergency department visits, opioid overdose, all-cause death … , opioid-related death, and nonopioid-related death. … hospitalization, nonopioid-specific hospitalization, emergency department visits, opioid overdose, all-cause death … , opioid-related death, and nonopioid-related death .

36. Executive Summary_Systematic Review: Interventions To Improve Care of Bereaved Persons (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bereaved-persons-research-executive-summ.pdf
    March 01, 2025 - symptoms. 2 Background and Purpose Bereavement, the state of having experienced the death … of someone close, and grief, the response to the death (and non-death), are fundamental aspects of … This intense grief is associated with high levels of distress following the death.2 This type of grief … , violent death, adults (vs pediatric sample) Low for potentially no effect Effect of Setting All … (vs non-U.S.) or setting of the death of the individual Low for potentially no effect Abbreviations

37. Omega-3 Fatty Acids and Cardiovascular Disease | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/fatty-acids-cardiovascular-disease/consumer
    November 01, 2020 - affect longer term cardiovascular problems such as the risk of heart attack, heart failure, stroke, death … from heart disease, and death from any cause. … supplements The risk of longer term CV problems (such as heart attack and heart failure) and death … Appears to lower the risk of longer term CV problems (such as heart attack and heart failure) and death … : Do not lower the risk of longer term CV problems (such as heart attack and heart failure) and death

38. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
    February 01, 2013 - This translates into approximately one death every minute.1,2 This report focuses on women because of … For women with STEMI, five studies showed a reduction in composite outcomes (primarily death/myocardial … At 1 year and beyond, although suggestive of a benefit of CABG for the composite outcomes of death/MI … fibrinolysis/supportive therapy on intermediate- or long-term clinical outcomes (nonfatal MI, death, … fibrinolysis/supportive therapy on intermediate- or long-term clinical outcomes (nonfatal MI, death,

39. Layout 1 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
    October 01, 2009 - Layout 1 Background Nearly 2,400 Americans die of cardiovascular disease each day, an average of one death … cardiovascular disease has accounted for more deaths than any other single cause or group of causes of death … Low • ARB therapy (telmisartan) may not reduce the composite efficacy endpoint of cardiovascular death … Low • ARB therapy (telmisartan) impacts the composite efficacy endpoint of cardiovascular death, nonfatal … ACE inhibitor therapy (perindopril, ramipril) reduces composite efficacy endpoints (cardiovascular death

40. Microsoft Word - finapps.doc (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
    January 01, 2007 - or kidney function worsening (by GFR, SCr, or dialysis), or atherosclerotic cardiovascular event, or death … aneurysm 1% Access site occlusion 0.3% Severe access site bleeding 2% 30 d mortality 0.6% Death … from tubular necrosis and multiorgan failure 0.7% Death from GI hemorrhage after stent implant while … after lower limb cholesterol embolization 1% Death after thrombosis of aortofemoral prosthetic … Brachial artery occlusion 1% Subacute stent thrombosis after 3 d 1% Groin hematoma 5% Ischemic cardiac